Quartz Bio publication -  Single Nucleotide Polymorphism Clustering in Systemic Autoimmune Diseases (by Thomas Charlon)

 

We are happy to annouce the publication of the manuscript "Single Nucleotide Polymorphism Clustering in Systemic Autoimmune Diseases" by Thomas Charlon, published in August in PLOS ONE. 

The article describes a clustering methodology aimed at removing the ancenstry bias in genetic analyses and uncovering disease-relevant traits. The project was conducted as part of the PRECISESADS consortium which is developping a new, biomarker-based, classification for inflammatory auto-immune disease.

 

 


Quartz Bio will be involved in the R Consortium ISC Code Coverage Working Group

Karl Forner, CIO of Quartz Bio has been invited to join the Code Coverage Working Group as part of the R Consortium, based on his previous work and contributions to R-coverage.
Code Coverage refers to the amount of code (for example in an R package) that is tested. Testing ensures that the code is fit for use. Therefore knowing what is actually being tested (covered) is essential to evaluate the robustness of software.

   Read more...
Quartz Bio now at the Geneva Campus Biotech

Quartz Bio has moved to the Geneva Campus Biotech. “Moving to your own offices is an important step in the life of a start-up”, says J. Wojcik CEO of Quartz Bio. “The FONGIT incubator has played an essential role in helping our company grow during the last three years”. The new offices will provide space to welcome our new collaborators in an innovation-driven environment aimed towards personalized medicine and digital health.


11th Annual Biomarkers Congress 2016

Quartz Bio will be sponsoring for the third time the Oxford Global Annual Biomarkers Congress (25th - 26th February - Manchester, UK). Come and meet us at our stand.


Celebrating our 3rd Anniversary

Quartz Bio is celebrating its 3rd anniversary. We thank all our clients for their renewed trust during these years and for their scientifically challenging projects. Thank you to all the Quarz Bio collaborators for making this venture a success story.


   Read more...